ExcelvisionJuly 7, 2023

FDA 483 - Excelvision - July 07, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Excelvision

Record Details

An FDA inspection of Excelvision, a drug manufacturer in Annonay, France, from June 29 to July 7, 2023, revealed significant deficiencies in aseptic processing. The firm's investigations into unexplained discrepancies and mold contamination were inadequate, and its cleaning, disinfection, and environmental monitoring systems were found to be deficient. These issues indicate a high risk of microbiological contamination for sterile drug products.

Company: Excelvision
Inspection Date: July 7, 2023
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Jeffrey P. Raimondi (Consumer Safety Officer)

Open in Dashboard

ID · ce597575-4f9b-4672-b921-3039a5eb2c51